Company No:
Contents
| DIRECTORS | Jessica Christine Marshall |
| Scott Marshall | |
| Tony Tams-Hudson (Resigned 02 September 2024) |
| REGISTERED OFFICE | White Swan Centre |
| Citadel East | |
| Newcastle Upon Tyne | |
| NE12 6SS | |
| United Kingdom |
| COMPANY NUMBER | 15662374 (England and Wales) |
| ACCOUNTANT | Ian Walker and Co |
| Wellington House | |
| Aviator Court | |
| York | |
| YO30 4UZ | |
| United Kingdom |
| Note | 2025 | |
| £ | ||
| Fixed assets | ||
| Investments | 3 |
|
| 272,943 | ||
| Current assets | ||
| Cash at bank and in hand | 4 |
|
| 5,311 | ||
| Creditors: amounts falling due within one year | 5 | (
|
| Net current liabilities | (181,940) | |
| Total assets less current liabilities | 91,003 | |
| Creditors: amounts falling due after more than one year | 6 | (
|
| Net assets |
|
|
| Capital and reserves | ||
| Called-up share capital | 7 |
|
| Total shareholders' funds |
|
Directors' responsibilities:
The financial statements of Nestnurturegroup Ltd (registered number:
|
Jessica Christine Marshall
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year, unless otherwise stated.
Nestnurturegroup Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is White Swan Centre, Citadel East, Newcastle Upon Tyne, NE12 6SS, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.
Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment.
| 2025 | |
| Number | |
| Monthly average number of persons employed by the Company during the year, including directors |
|
| 2025 | |
| £ | |
| Other investments and loans |
|
Investments in subsidiaries
| 2025 | |
| £ | |
| Cost | |
| At 01 May 2024 | 0 |
| Additions |
|
| At 30 April 2025 |
|
| Provisions for impairment | |
| At 01 May 2024 | 0 |
| Disposals |
|
| At 30 April 2025 |
|
| Carrying value at 30 April 2025 |
|
| 2025 | |
| £ | |
| Cash at bank and in hand |
|
| 2025 | |
| £ | |
| Bank loans |
|
| Amounts owed to Group undertakings |
|
| Other creditors |
|
|
|
| 2025 | |
| £ | |
| Bank loans |
|
| 2025 | |
| £ | |
| Allotted, called-up and fully-paid | |
|
|
|